• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三碘甲状腺原氨酸对大鼠前脑 5-HT1A 和 5-HT1B 受体表达及新异环境摄食抑制试验摄食潜伏期的影响。

Effect of triiodothyronine on 5-HT1A and 5-HT1B receptor expression in rat forebrain and on latency to feed in the novelty suppressed feeding test.

机构信息

Biological Psychiatry Laboratory, Department of Psychiatry, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel.

出版信息

Prog Neuropsychopharmacol Biol Psychiatry. 2010 May 30;34(4):632-8. doi: 10.1016/j.pnpbp.2010.02.029. Epub 2010 Mar 4.

DOI:10.1016/j.pnpbp.2010.02.029
PMID:20206658
Abstract

Thyroid hormones, particularly triiodothyronine (T3), have long been used for the treatment of depression, most frequently to enhance the therapeutic activity of other antidepressants. The purpose of this study was to evaluate possible underlying mechanisms for the antidepressant activity of T3. The effects of T3 20 microg/kg/d S.C. and fluoxetine 5mg/kg/d I.P. given alone or in combination for 7 days on the transcription rates of inhibitory serotonergic receptors (5-HT1A and 5-HT1B) were studied in different brain areas of male Sabra rats using real-time PCR. Significant effects of fluoxetine were found on the expression of 5-HT1B receptors in the frontal cortex and of T3 on the expression of 5-HT1A receptors in the amygdala and hippocampus and 5-HT1B receptors in the frontal and entorhinal cortices, the expression being reduced in all cases. An effect of the combination of T3 plus fluoxetine to reduce transcription was observed for 5-HT1A receptors, in the amygdala and dentate gyrus and for 5-HT1B receptors in the entorhinal cortex and anterior raphe nucleus. In the second experiment, the novelty suppressed feeding test (NFST) was used to examine the effects of fluoxetine 5mg/kg/d I.P. and T3 20 or 50 microg/kg/d, alone or in combination for 12 days, on latency to feed. Only the combinations of T3 (20 or 50 microg/kg/d) and fluoxetine (5mg/kg/d) yielded significant behavioral effects in this test. The results of our studies suggest that the mechanism underlying the antidepressant effect of T3 may involve a reduction in 5-HT1A and 5-HT1B receptor transcription rates.

摘要

甲状腺激素,特别是三碘甲状腺原氨酸(T3),长期以来一直被用于治疗抑郁症,最常用于增强其他抗抑郁药的治疗活性。本研究的目的是评估 T3 抗抑郁活性的潜在机制。使用实时 PCR 研究了 T3 20μg/kg/d sc 和氟西汀 5mg/kg/d ip 单独或联合给药 7 天对雄性 Sabra 大鼠不同脑区抑制性 5-羟色胺能受体(5-HT1A 和 5-HT1B)转录率的影响。发现氟西汀对前额叶皮层中 5-HT1B 受体的表达有显著影响,T3 对杏仁核和海马中 5-HT1A 受体的表达和前额叶和内嗅皮质中 5-HT1B 受体的表达有显著影响,所有情况下的表达均减少。观察到 T3 加氟西汀联合减少转录的效应,用于 5-HT1A 受体,在杏仁核和齿状回,以及 5-HT1B 受体,在内嗅皮质和前中缝核。在第二个实验中,使用新颖性抑制进食测试(NFST)来检查氟西汀 5mg/kg/d ip 和 T3 20 或 50μg/kg/d,单独或联合给药 12 天,对进食潜伏期的影响。只有 T3(20 或 50μg/kg/d)和氟西汀(5mg/kg/d)的组合在该测试中产生了显著的行为效应。我们的研究结果表明,T3 抗抑郁作用的机制可能涉及减少 5-HT1A 和 5-HT1B 受体转录率。

相似文献

1
Effect of triiodothyronine on 5-HT1A and 5-HT1B receptor expression in rat forebrain and on latency to feed in the novelty suppressed feeding test.三碘甲状腺原氨酸对大鼠前脑 5-HT1A 和 5-HT1B 受体表达及新异环境摄食抑制试验摄食潜伏期的影响。
Prog Neuropsychopharmacol Biol Psychiatry. 2010 May 30;34(4):632-8. doi: 10.1016/j.pnpbp.2010.02.029. Epub 2010 Mar 4.
2
Effects of triiodothyronine and fluoxetine on 5-HT1A and 5-HT1B autoreceptor activity in rat brain: regional differences.三碘甲状腺原氨酸和氟西汀对大鼠脑内5-HT1A和5-HT1B自身受体活性的影响:区域差异
J Neurosci Methods. 2004 Dec 30;140(1-2):133-9. doi: 10.1016/j.jneumeth.2004.03.028.
3
Loss of Adult 5-HT1A Autoreceptors Results in a Paradoxical Anxiogenic Response to Antidepressant Treatment.5-HT1A 自身受体缺失导致抗抑郁治疗的反常焦虑反应。
J Neurosci. 2019 Feb 20;39(8):1334-1346. doi: 10.1523/JNEUROSCI.0352-18.2018. Epub 2018 Dec 14.
4
SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue.SB-649915,一种新型、强效的5-羟色胺1A和5-羟色胺1B自身受体拮抗剂,也是天然组织中的5-羟色胺再摄取抑制剂。
Eur J Pharmacol. 2006 Apr 24;536(1-2):54-61. doi: 10.1016/j.ejphar.2006.02.042. Epub 2006 Feb 28.
5
Chronic effects of corticosterone on GIRK1-3 subunits and 5-HT1A receptor expression in rat brain and their reversal by concurrent fluoxetine treatment.皮质酮对大鼠脑内 GIRK1-3 亚基和 5-HT1A 受体表达的慢性影响及其与氟西汀同时治疗的逆转。
Eur Neuropsychopharmacol. 2013 Mar;23(3):229-39. doi: 10.1016/j.euroneuro.2012.04.007. Epub 2012 May 15.
6
Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors.单独使用(-)-吲哚洛尔以及与5-羟色胺再摄取抑制剂联合使用对自由活动大鼠额叶皮质中多巴胺、去甲肾上腺素和5-羟色胺(5-HT)透析液水平的调节:β-肾上腺素能、5-HT1A和5-HT1B受体的比较作用
Neuropsychopharmacology. 1999 Aug;21(2):268-84. doi: 10.1016/S0893-133X(99)00035-4.
7
Differential adaptation of brain 5-HT1A and 5-HT1B receptors and 5-HT transporter in rats treated chronically with fluoxetine.长期服用氟西汀的大鼠脑内5-羟色胺1A和5-羟色胺1B受体及5-羟色胺转运体的差异适应性
Neuropharmacology. 2000;39(1):110-22. doi: 10.1016/s0028-3908(99)00088-x.
8
WAY100635 prevents the changes induced by fluoxetine upon the 5-HT1A receptor functionality.WAY100635可防止氟西汀引起的5-HT1A受体功能变化。
Neuropharmacology. 2008 Dec;55(8):1391-6. doi: 10.1016/j.neuropharm.2008.08.038. Epub 2008 Sep 17.
9
Deep brain stimulation and fluoxetine exert different long-term changes in the serotonergic system.深部脑刺激和氟西汀对 5-羟色胺能系统产生不同的长期变化。
Neuropharmacology. 2018 Jun;135:63-72. doi: 10.1016/j.neuropharm.2018.03.005. Epub 2018 Mar 2.
10
Depressive-like state sensitizes 5-HT and 5-HT auto-receptors in the dorsal raphe nucleus sub-system.抑郁样状态使中缝背核亚系的 5-HT 和 5-HT 自身受体敏感。
Behav Brain Res. 2020 Jul 1;389:112618. doi: 10.1016/j.bbr.2020.112618. Epub 2020 Apr 28.

引用本文的文献

1
Effect of triiodothyronine (T(3)) augmentation of acute milnacipran administration on monoamine levels: an in vivo microdialysis study in rats.三碘甲状腺原氨酸(T(3))增强米那普仑急性给药对单胺水平的影响:大鼠体内微透析研究。
Neuropsychiatr Dis Treat. 2012;8:501-7. doi: 10.2147/NDT.S36906. Epub 2012 Oct 30.